• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Yousuf Zafar Explains How Financial Toxicity Impacts Cancer Patients

Video

The term financial toxicity is relatively new and is being used to draw parallels between the physical toxicities of chemotherapy and the cost-related burdens cancer patients face.

Insured cancer patients who are experiencing more and more out-of-pocket costs are finding themselves having to cut back on basics like food and clothing, Yousuf Zafar, MD, associate professor of medicine at the Duke Cancer Institute, said in December at the 2014 Annual Meeting of the American Society of Hematology.

The term financial toxicity is relatively new and it is used to draw parallels between the physical toxicities of chemotherapy and the cost-related burdens cancer patients feel, he explained.

“There is a direct and concrete impact of financial toxicity on the quality of cancer care,” Dr Zafar added.

Related Videos
Joshua K. Sabari, MD
Nicoletta Colombo, MD, PhD
Khush Kharidia, MD
Jo Varshney, PhD, DVM, CEO and founder, VeriSIM Life
Kimberly Westrich, MA, chief strategy officer, National Pharmaceutical Council
Harry Travis, BS Pharm, MBA, president at The Travis Group, LLC
 Brigid Groves, PharmD, MS, vice president, professional affairs, American Pharmacists Association
Chelsea Renfro, PharmD, research and engagement pharmacist, Vanderbilt Specialty Pharmacy
Marc S. Raab, MD, PhD, University Hospital Heidelberg
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.